Historical record - last NADAC effective date: 7/1/2017
Product Information
NAPRELAN CR 750 MG TABLET is a brand product labeled by Almatica Pharma LLC, priced at $22.1736 per EA under NDC 52427027430. Its NADAC has been published 148 times since Sep 16, 2015.
FDA first approved this application on Jan 5, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Naproxen Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427027430
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
7/1/2017
Active Ingredients
NAPROXEN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020353FDA Approved
1/5/1996
TE Code
AB
On Market Since
1/17/2014
Pharmacological Classes
Price Statistics
The NADAC for NAPRELAN CR 750 MG TABLET has been published 148 times since Sep 16, 2015, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.1736 per EA |
|---|---|
| All-time high | $22.1736 (Jul 11, 2018) |
| All-time low | $19.1600 (Dec 23, 2015) |
| Median price | $21.5280 |
| Average price | $20.8762 |
| Largest weekly change | +6.0% (Jul 27, 2016) |
| Weeks tracked | 148 |
| Tracking since | Sep 16, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+13.6%
Last surveyed Jul 11, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPRELAN CR 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPRELAN CR 750 MG TABLET, manufactured by Almatica Pharma LLC, is $22.1736 per EA (NDC 52427027430), effective Jul 11, 2018.
How has the price of NAPRELAN CR 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPRELAN CR 750 MG TABLET has risen 13.6%. It has been tracked across 148 weekly CMS publications since Sep 16, 2015.
What are the highest and lowest recorded NADAC prices for NAPRELAN CR 750 MG TABLET?
Since Sep 16, 2015, the NADAC for NAPRELAN CR 750 MG TABLET has ranged from a low of $19.1600 (Dec 23, 2015) to a high of $22.1736 (Jul 11, 2018), with a median of $21.5280 per EA.
Are there cheaper alternatives to NAPRELAN CR 750 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NAPRELAN CR 750 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAPRELAN CR 750 MG TABLET?
NAPRELAN CR 750 MG TABLET (NDC 52427027430) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.